Truist Financial Corp Biolife Solutions Inc Transaction History

Truist Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 17, 2023	SELL	$16.95 - $25.07 $6,068 - $8,975	-358 Reduced 2.65%	13,131 $238,000
Q3 2022 Oct 26, 2022	BUY	$14.64 - $26.7 $197,478 - $360,156	13,489 New	13,489 $307,000
Q2 2022 Jul 22, 2022	SELL	$10.54 - $24.2 $96,251 - $220,994	-9,132 Closed	0 $0
Q1 2022 Apr 22, 2022	BUY	$20.81 - $37.29 $190,036 - $340,532	9,132 New	9,132 $208,000

188

47.1M

4.3K

4.7K

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.11B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Truist Financial Corp with notifications on news.